Photosensitivity disorders: cause, effect and management

作者: Thomas P. Millard , John L.M. Hawk

DOI: 10.2165/00128071-200203040-00002

关键词: PhotosensitivityChronic actinic dermatitisAzathioprineSolar urticariaDermatologyHydroa vacciniformeMedicineCetirizineFexofenadineActinic prurigo

摘要: Abnormal photosensitivity syndromes form a significant and common group of skin diseases. They include primary (idiopathic) photodermatoses such as polymorphic light eruption (PLE), chronic actinic dermatitis (CAD), prurigo, hydroa vacciniforme solar urticaria, in addition to drug- chemical-induced photo-exacerbated dermatoses. can be extremely disabling difficult diagnose. PLE, characterized by recurrent pruritic papulo-vesicular affected within hours sun exposure, is best managed restriction ultraviolet radiation (UVR) exposure the use high protection factor (SPF) sunscreens. If these measures are insufficient, prophylactic phototherapy with PUVA, broadband UVB or narrowband (TL-01) for several weeks during spring may necessary. CAD manifests chronically sun-exposed skin. Again, UVR needs restricted; cyclosporine, azathioprine PUVA also Actinic prurigo presence excoriated papules nodules on face limbs, most prominent numerous distally. again SPF sunscreens; therapy, low doses thalidomide Hydroa causes crops discrete erythematous macules, 2 3mm size, that evolve into blisters couple days exposure. Treatment this rare disease difficult; absorbent sunscreens restricted help. Solar urticaria acute erythema urticarial wealing after UVR. options non-sedating antihistamines fexofenadine cetirizine; other sunscreens, at relevant wavelength, maintenance non-responsive state natural artificial plasmapheresis. Industrial, cosmetic therapeutic agents induce exogenous photosensitivity. The clinical pattern highly varied, depending agent; treatment based removal photosensitizer along Predominantly non-photosensitive dermatoses exacerbated precipitated UVR; should reduced advocated, appropriate underlying disease.

参考文章(10)
Diffey Bl, Human exposure to ultraviolet radiation. Seminars in Dermatology. ,vol. 9, pp. 2- 10 ,(1990)
Johnson Be, Ferguson J, Drug and chemical photosensitivity. Seminars in Dermatology. ,vol. 9, pp. 39- 46 ,(1990)
C. PAO, P.G. NORRIS, M. CORBETT, J.L.M. HAWK, Polymorphic light eruption: prevalence in Australia and England British Journal of Dermatology. ,vol. 130, pp. 62- 64 ,(1994) , 10.1111/J.1365-2133.1994.TB06884.X
F. A. IVE, I. A. MAGNUS, R. P. WARTN, E. WILSON JONES, “ACTINIC RETICULOID”: A CHRONIC DKHMATOSIS ASSOCIATED WITH SEVERE PHOTOSENSITIVITY AND THE HISTOLOGICAL RESEMBLANCE TO LYMPHOMA British Journal of Dermatology. ,vol. 81, pp. 469- 485 ,(1969) , 10.1111/J.1365-2133.1969.TB16022.X
TP Millard, JLM Hawk, LB Travis, JM McGregor, Treatment of polymorphic light eruption Journal of Dermatological Treatment. ,vol. 11, pp. 195- 199 ,(2000) , 10.1080/09546630050517360
W. FRAIN-BELL, T. LAKSHMIPATHI, J. ROGERS, JOYCE WILLOCK, The syndrome of chronic photosensitivity dermatitis and actinic reticuloid. British Journal of Dermatology. ,vol. 91, pp. 617- 634 ,(1974) , 10.1111/J.1365-2133.1974.TB12450.X
GRABCZYNSKA, MCGREGOR, KONDEATIS, VAUGHAN, HAWK, Actinic prurigo and polymorphic light eruption: common pathogenesis and the importance of HLA-DR4/DRB1*0407. British Journal of Dermatology. ,vol. 140, pp. 232- 236 ,(1999) , 10.1046/J.1365-2133.1999.02654.X
Thomas P. Millard, Veronique Bataille, Harold Snieder, Tim D. Spector, Jane M. McGregor, The Heritability of Polymorphic Light Eruption Journal of Investigative Dermatology. ,vol. 115, pp. 467- 470 ,(2000) , 10.1046/J.1523-1747.2000.00079.X
D. BILSLAND, S.A. GEORGE, N.K. GIBBS, T. AITCHISON, B.E. JOHNSON, J. FERGUSON, A comparison of narrow band phototherapy (TL‐01) and photochemotherapy (PUVA) in the management of polymorphic light eruption British Journal of Dermatology. ,vol. 129, pp. 708- 712 ,(1993) , 10.1111/J.1365-2133.1993.TB03337.X